Liver resection of transplantation for hepatocellular carcinoma?: Restrospective analysis of 215 patients with cirrhosis
References (24)
- et al.
Resection of hepatocellular carcinomas.
Gastrenterology
(1990) - et al.
- et al.
Carcinomes hépatocellulaires en France.
Gastroenterol Clin Biol
(1985) - et al.
- et al.
Current treatment modalities for hepatocellular carcinoma
Ann Surg
(1994) - et al.
Natural history of hepatocellular carcimona in relation to treatment.
Cancer
(1985) - et al.
Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis.
Ann Surg
(1991) - et al.
Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy
Cancer
(1992) - et al.
Postoperative recurrence of hepatocellular carcinoma.
Ann Surg
(1990) - et al.
Assessment of pattern and treatment of intrahepatic recurrence after resection of hepatocellular carcinoma
Surg Gynecol Obstet
(1990)
Résections des carcinomes hépatocellulaires, analyse des facteurs pronostiques d'une série multicentrique de 153 malades.
Gastroenterol Clin Biol
(1993)
The role of liver transplantation in hepatobility malignancy.
Ann Surg
(1989)
Cited by (151)
Changes of long-term survival of resection and liver transplantation in hepatocellular carcinoma throughout the years: A meta-analysis
2024, European Journal of Surgical OncologyImpact of radiation therapy and alpha-fetoprotein level on survival outcomes for patients with hepatocellular carcinoma: A population-based study
2023, Clinics and Research in Hepatology and GastroenterologyTherapeutic Ultrasound Parameter Optimization for Drug Delivery Applied to a Murine Model of Hepatocellular Carcinoma
2021, Ultrasound in Medicine and BiologyLongitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma
2018, Journal of Controlled ReleaseChanging Paradigm in the Surgical Management of Hepatocellular Carcinoma With Salvage Transplantation
2018, Transplantation ProceedingsDe novo hepatocellular carcinoma of liver allograft: A neglected issue
2015, Cancer LettersCitation Excerpt :Albeit this transplant policy has remarkably reduced the risk of recurrence, HCC reappears in approximately 20% of patients [6]. This is believed to derive from extrahepatic tumor-cell dissemination before OLT [6], leading to cancer resurfacing outside or, more frequently, within the liver [7–10]. However, another type of carcinogenesis may affect the graft, i.e. a de novo appearance of a secondary new HCC, independent of the tumor of the native liver.
Copyright © 1997 Published by Elsevier Ireland Ltd.